ÂÜÀòÂÒÂ×

The Clinical Development and Research team at Bolt Biotherapeutics is responsible for designing and executing clinical trials to evaluate the safety and efficacy of Boltbodyâ„¢ Immune-stimulating Antibody Conjugates (ISAC) in treating tumors. This multidisciplinary team collaborates closely on translational medicine, toxicology, and analytical development, aiming to advance innovative therapies from preclinical studies to human applications and ultimately improve patient outcomes in immuno-oncology.